AstraZeneca has been granted protection from product liability claims related to its Covid-19 vaccine by most of the countries with which it has struck supply agreements.

After reports of a rare blood clots associated with the vaccine this year, several countries announced restrictions on its use in younger people.

In Asia, countries including Singapore, Australia, Thailand and Malaysia have financial assistance programmes or set up compensation funds for those who suffer serious side effects from vaccines.